The GENLISA Human Breast Cancer Susceptibility Protein 2 (BRCA2) ELISA includes features like: - Ready to use protocol with break-apart wells for ease of use - Standardisation and High Reproducibility - Lot to Lot Consistency - Accuracy and Precision Validated against seven points for a ''GOLD RING Standard Quality ELISA - the benchmark sign for Krishgen Quality. The The GENLISA ELISA kits are used for assessing the specific biomarker in samples analytes which may be human serum, plasma, biological fluids and cell culture supernatant. The kit uses indirect sandwich assay with double antibodies - capture and detection to ensure a high degree of sensitivity and specificity in the estimation of Breast Cancer Susceptibility Protein 2 (BRCA2), BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast Cancer 2,Early Onset, Breast Cancer Type 2 Susceptibility Protein, Fanconi anemia group D1 protein
Range:
0.156 - 10 ng/ml
Sensitivity:
0.062 ng/ml
Samples:
Serum, Plasma, Cell Culture Supernatant and other biological samples. Validated for citrated/EDTA Plasma only.
Application Notes:
Colorimetric, Absorbance measured at 450nm
* VAT and and shipping costs not included. Errors and price changes excepted
